Clinical Trial Update: Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the addition of curcumin to standard treatment for endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: University Hospital, Gasthuisberg | Conditions: Endometrial Carcinoma | Phase 2 | Status: COMPLETED